ProtaGene Earns CAP and CLIA Accreditation for Gene Therapy Safety Testing
ProtaGene’s Heidelberg, Germany, lab has received CAP and CLIA accreditation, authorizing integration site analysis on human samples for lentivirus-based cell and gene therapy under U.S. federal regulations.